Browsing by Author "CLARITY Study Investigators, CLARITYSI"
Now showing items 1-1 of 1
-
Neutralising antibody potency against SARS-CoV-2 wild- type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Liu, Z; Le, K; Zhou, X; Alexander, JL; Lin, S; Bewshea, C; Chanchlani, N; Nice, R; McDonald, TJ; Lamb, CA (2023)